A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2–positive breast cancer (TUTOR)
Publication Date
6-1-2024
Presented At:
American Society of Clinical Oncology (ASCO) Annual Meeting
Citation
Ahluwalia, Manmeet; Ozair, Ahmad; Bardhan, Mainak; Perche, Dilanis; Rubens, Muni; Odia, Yazmin; Kotecha, Rupesh; Leon Ariza, Daniel; McDermott, Michael; Sandoval Leon, Ana Cristina; Mahtani, Reshma; Bellur, Shreyas; and Peereboom, David, "A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2–positive breast cancer (TUTOR)" (2024). All Publications. 5484.
https://scholarlycommons.baptisthealth.net/se-all-publications/5484